Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking the MARS imaging system for its applications in medical diagnosis. The MARS imaging system is based on the new generation Medipix chip licensed out of CERN, Switzerland and technology developed by the University of Canterbury (UC) and partners. It has established itself as the world’s leading spectral (multi-energy ‘true colour’) imaging technology. It is the first commercially available spectral, high definition computed tomography (CT) system and has already demonstrated exciting applications.
Looking for a particular MARS Bioimaging Ltd employee's phone or email?
The MARS Bioimaging Ltd annual revenue was $5 million in 2026.
Robert Senzig is the Vice President Clinical Engineering of MARS Bioimaging Ltd.
10 people are employed at MARS Bioimaging Ltd.
MARS Bioimaging Ltd is based in Christchurch, Canterbury.
The NAICS codes for MARS Bioimaging Ltd are [33, 334].
The SIC codes for MARS Bioimaging Ltd are [38, 384].